Introduction
============

Avian pathogenic *Escherichia coli* (APEC), an important extraintestinal pathogenic *E. coli* (ExPEC), causes colibacillosis, an acute systemic disease that involves multiple organ lesions including respiratory, digestive, vascular and nervous system diseases ([@ref-18]; [@ref-21]). Previous studies have demonstrated that APEC strains with different serotypes (O18, O2, O1) can induce meningitis in newborn mammals, such as mice, with varying degrees of septicemia via pathogenic mechanisms that are similar to those of neonatal meningitis-causing *E. coli* (NMEC) strains ([@ref-43]; [@ref-48]; [@ref-83]). The APEC XM strain (O2:K1), isolated from the brain of a duck with septicemia and meningitis, was shown to be involved in the systemic infection of 7-day-old ducks and 5-week-old Institute of Cancer Research mice, causing severe meningitis in a neonatal mouse model ([@ref-28]; [@ref-45]).

Various bacterial factors have been recognized as potent or putative virulence factors of APEC strains, including adhesins (Fim, Pap and Mat), iron acquisition systems (siderophores), two-component regulatory systems (RstAB system, ArcA/B system), vacuolating autotransporter toxin located in the chromosome, and the ColV plasmid encoded virulence genes ([@ref-8]; [@ref-23]; [@ref-32]; [@ref-81]). In particular, it has been reported that the virulence genes *ibeA* and *gimB*, which contribute to the invasion of host cells, are shared between APEC and NMEC ([@ref-3]; [@ref-56]). Moreover, the host cell cytosolic phospholipase A~2~ and *E. coli ibeA* gene have been proved to be involved in the invasion of brain microvascular endothelial cells (BMECs) ([@ref-14]; [@ref-46]; [@ref-84]). Since APEC is a potential reservoir of ExPEC virulence genes and pathogenic to humans ([@ref-58]), APEC infection may pose a potential risk for zoonotic transfer ([@ref-50]). *E. coli* usually causes meningitis via several steps involving bacteria--host interactions: entry into the gastrointestinal tract mucosa ([@ref-6]), invasion of the intravascular space, survival and multiplication in the serum to a particular order of magnitude ([@ref-67]), traversing through the blood--brain barrier (BBB), and ultimately contributing to central nervous system (CNS) complications and neuronal injury ([@ref-36]; [@ref-76]). A critical step in meningitic process is the bacterial crossing of the BBB, a structural and functional barrier formed by BMECs, astrocytes and pericytes that blocks the transport of harmful substances and pathogenic microorganisms. Bacteria invade the BBB via intercellular and paracellular pathways as well as Trojan horse mechanisms ([@ref-35], [@ref-37]). However, the mechanisms involved in the bacteria-host interaction during this process remain unclear.

Bacteria can rapidly reprogram their gene expression networks in response to their constantly changing living environment. During in vivo infection, the bacteria compete with the host for survival or nutrition and gene expression changes are observed in both, which differ from those observed in artificial culture conditions. Dual RNA sequencing (RNA-seq) was first used to simultaneously profile host and pathogen transcriptomes in 2012 in order to better understand the host--pathogen interactions ([@ref-75]). Since then, dual RNA-seq analyses have been successfully performed to assess pathogen--host interactions, including those between *Pseudomonas plecoglossicida* and *Epinephelus coioides* ([@ref-80]) as well as *Salmonella* and HeLa cells ([@ref-74]). However, the interaction between *E. coli* and BBB-related cells has not yet been explored by dual RNA-seq.

In this study, we investigated the potential mechanism of APEC-host cell interaction by infecting the mouse brain microvascular endothelial cell line (bEnd.3) with the APEC XM strain (O2:K1). The transcriptomes of APEC strain and bEnd.3 cells were measured by dual RNA-seq during the interaction. The findings of this study may contribute toward improving the current understanding of *E. coli* invasion across the BBB.

Materials and Methods
=====================

Culture conditions
------------------

The APEC XM strain (O2:K1) was isolated from the brain of a duck with symptoms of septicemia and meningitis (donated by Dr. Guoqiang Zhu, Yangzhou University), and grown aerobically on Luria-Bertani (LB) plates or in LB broth with agitation (180 rpm/min) at 37 °C. Mouse BMECs (bEnd.3; ATCC CRL-2299, American Type Culture Collection, Manassas, VA, USA) were cultured in Dulbecco's Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, CA, USA), supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco, Carlsbad, CA, USA) in 10 cm cell culture dishes at 37 °C in a 5% CO~2~ atmosphere.

Bacterial adherence and invasion of bEnd.3 cells
------------------------------------------------

For the adherence and invasion assays, the APEC strain was grown in LB broth with agitation (180 rpm/min) until the optical density at 600 nm reached 1.0 (1 × 10^8^ CFU/mL) in exponential phase. The bacteria were collected by centrifugation (3,500 rpm, 8 min), washed twice with phosphate-buffered saline (PBS), and resuspended in FBS-free DMEM. Then, bEnd.3 cells were infected with the APEC XM strain in 10 cm dishes at a multiplicity of infection (MOI) of 100 for 1, 2, 3, 4, 5 or 6 h at 37 °C in 5% CO~2~. The mock-infection cells were cultured in FBS-free DMEM as control. The bEnd.3 cells were gently washed with PBS three times to remove any non-adherent bacteria, and then lysed with 0.5% Triton X-100 for 30 min at 37 °C. The suspensions were collected, serially diluted 10-fold, and plated on LB plates. After incubation overnight at 37 °C, the number of CFUs was calculated. The time point at which the highest number of bacteria adhered to and invaded the bEnd.3 cells was selected for the sample collection and RNA-seq analysis.

Total RNA isolation
-------------------

Bacteria were cultured in DMEM without FBS for 3 h and then were treated with RNAprotect Bacteria Reagent (QIAGEN, Hilden, Germany) to protect the RNA. Total RNA was extracted using TRIzol reagent according to the manufacturer's instructions (Invitrogen Co., Ltd., San Diego, CA, USA) and genomic DNA was digested using RNase-free DNase. To sequence the bacterial transcriptome, rRNA was removed from the total RNA using a Ribo-Zero rRNA removal kit (gram-negative bacteria, Epicentre Biotechnologies, Madison, WI, USA). The total RNA of bEnd.3 cells, infected with or without APEC for 3 h, were isolated using pre-cooled TRIzol reagent (Invitrogen Co., Ltd., San Diego, CA, USA) according to the manufacturer's instructions. RNA integrity was analyzed using an Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA), RNA purity was checked using a NanoPhotometer^®^ spectrophotometer (IMPLEN, Westlake Village, CA, USA), and RNA concentration was measured using a Qubit^®^ RNA Assay Kit with a Qubit^®^ 2.0 Fluorometer (Invitrogen Co., Ltd., San Diego, CA, USA).

cDNA library construction and RNA-seq
-------------------------------------

Nine individual cDNA sequencing libraries (three mock infection APEC samples, three mock-infected bEnd.3 samples, and three infection samples) were prepared using a NEBNext^®^ UltraTM RNA Library Prep Kit for Illumina^®^ (NEB, Ipswich, MA, USA) according to the manufacturer's recommendations. Index codes were added to attribute sequences to each sample. Briefly, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads and fragmented using divalent cations under high temperatures in NEBNext First Strand Synthesis Reaction Buffer (5×) (NEB, Ipswich, MA, USA). cDNA was synthesized using a random hexamer primer and fragments of 250--300 bp in length were preferentially selected and purified using an AMPure XP system (Beckman Coulter, Brea, CA, USA). PCR was then performed using a Phusion High-Fidelity DNA polymerase (Vazyme, Nanjing, China), universal PCR primers, and Index (X) primers. The PCR products were purified using an AMPure XP system (Beckman Coulter, Brea, CA, USA) and library quality was assessed using an Agilent Bioanalyzer 2100 system (Agilent Technologies, Palo Alto, CA, USA). The index-coded samples were clustered using a cBot Cluster Generation System (Illumina, Inc., San Diego, CA, USA) with a TruSeqPE Cluster Kit v3-cBot-HS (Illumina, Inc., San Diego, CA, USA) according to the manufacturer's instructions. The library was then sequenced on an Illumina HiSeq platform (Illumina, Inc., San Diego, CA, USA) to generate 125/150 bp paired-end reads. The raw reads in FASTQ format were first processed using in-house Perl scripts and clean data were obtained by removing reads containing adaptor or poly-N sequences and low-quality reads. The Q20, Q30 and GC content of the clean data were then calculated. Bowtie2-2.2.3 was used to build the reference genome index and align the clean reads to the reference genome. HTSeq v0.6.1 was used to count the number of reads mapped to each gene. Gene transcription levels were estimated by calculating the fragments per kilobase of transcript per million mapped reads.

Differentially expressed genes screening and functional analysis
----------------------------------------------------------------

The DEGs in bEnd.3 cells and APEC were evaluated by comparing the transcriptome data of both cell types cultured in DMEM or during their interaction using the DESeq2 R package (1.16.1). The *P* values of results were adjusted using Benjamini and Hochberg's approach to control the false discovery rate. Differential expression was determined using the following thresholds: \|log~2~-fold change\| of ≥1 or 0.5 and an adjusted *P* value of ≤0.05.

DEG functional annotation and enrichment were performed using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, while KOBAS software was used to test the statistical enrichment of DEGs in KEGG pathways and the GOseq R package was used to analyze the GO enrichment of DEGs. GO terms with corrected *P* values of less than 0.05 were considered to be significantly enriched for DEGs.

Quantitative real-time PCR
--------------------------

qRT-PCR was carried out using a previously described method for validating gene expression data obtained by high-throughput profiling platforms ([@ref-20]). A total of 17 genes were randomly selected to analyze their relative expression level and then qRT-PCR primers were designed and validated for these genes ([Table S1](#supp-2){ref-type="supplementary-material"}). qRT-PCR was carried out on a CFX CONNECT Real-time PCR machine (Bio-Rad, Louisville, KY, USA) using ChamQ SYBR qRT-PCR Master Mix (2×) (Vazyme, Nanjing, China) according to the manufacturer's instructions. The amplification cycles were performed as follows: 95 °C for 10 min, followed by 40 cycles of 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s. All qRT-PCR assays were performed in triplicate, with expression values estimated using the 2^−ΔΔCt^ method and normalized using *gapA* and *GADPH* for APEC and bEnd.3 cells, respectively. The correlation between the fold changes obtained by qRT-PCR and RNA-seq were determined using Pearson correlation analysis.

Results
=======

Ability of APEC to adhere to and invade bEnd.3 cells
----------------------------------------------------

To characterize the interactions between the APEC strain and the BBB, bEnd.3 cells were used to establish an in vitro model. The ability of adhesion and invasion at six serial time points were evaluated. MOI of 100 was identified as the appropriate infectious dose of bacteria and the maximum adhesion and invasion was achieved at 3 h ([Fig. S1](#supp-1){ref-type="supplementary-material"}).

Dual RNA-seq analysis of APEC and infected bEnd.3 cells
-------------------------------------------------------

To characterize the response of bEnd.3 cells to infection and investigate the effect of bEnd.3 cells resistance on the transcriptional response of *E. coli* in vitro, we used a dual RNA-seq method that enabled the simultaneous transcriptional profiling of bacteria and bEnd.3 cells. Total RNA, including cellular and bacterial RNA, was isolated from infected bEnd.3 cells at 3 h. Nine individual cDNA sequencing libraries (three mock infection APEC samples, three mock-infected bEnd.3 samples, and three infection samples) were prepared and sequenced using the Illumina paired-end method, generating more than 1 × 10^7^ clean reads per group after removal of the low-quality reads ([Table 1](#table-1){ref-type="table"}). The clean reads of Q20 and Q30 were above 97% and 91%, respectively, with a GC content of approximately 50%. Next, we mapped the sequenced clean reads to the *Mus musculus* (Ensembl release-92) and *E. coli* (GCF_002844685.1) genomes. In the bEnd.3 cell-APEC interaction (be_AP) group, over 65% of the clean reads were mapped to the *M. musculus* genome and less than 20% were mapped to the *E. coli* genome, providing sufficient data for further analysis. In the two control groups, more than 92% and 99% of the clean reads were mapped to the *E. coli* and *M. musculus* genomes, respectively. All further analyses were based on the uniquely mapped reads and all raw data were submitted to the ZENODO database ([DOI 10.5281/zenodo.3689240](DOI 10.5281/zenodo.3689240), [10.5281/zenodo.3672826](10.5281/zenodo.3672826)).
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###### Summary of illumina RNA-seq data.

Each row of data indicates the total reads, clean reads, total mapped clean data, Q30 (%), GC (%), and percent sequence reads mapped of every sample.
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  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sample       Total reads   Clean reads   Total mapped clean data[\*](#table-1fn1){ref-type="fn"} (Gb)   Q30\    GC\                                      Mapped\
                                                                                                          (%)     (%)                                      rate (%)
  ------------ ------------- ------------- -------------------------------------------------------------- ------- ---------------------------------------- ----------------------------------------
  APEC_1       11,377,278    11,303,464    1.7G                                                           92.84   51.33                                    99.43[^a^](#table-1fn2){ref-type="fn"}

  APEC_2       12,595,278    12,482,110    1.87G                                                          92.86   51.46                                    99.39[^a^](#table-1fn2){ref-type="fn"}

  APEC_3       9,850,068     9,786,504     1.47G                                                          94.91   51.45                                    99.72[^a^](#table-1fn2){ref-type="fn"}

  bEnd3_1      59,805,426    59,042,776    8.86G                                                          92.05   50.7                                     92.44[^b^](#table-1fn3){ref-type="fn"}

  bEnd3_2      49,924,482    49,319,300    7.4G                                                           92.1    51.22                                    92.46[^b^](#table-1fn3){ref-type="fn"}

  bEnd3_3      64,453,186    63,528,514    9.53G                                                          91.87   50.15                                    92.29[^b^](#table-1fn3){ref-type="fn"}

  bE_AP_1      77,516,134    76,516,858    11.48G                                                         92.15   48.91                                    19.16[^a^](#table-1fn2){ref-type="fn"}

  79,574,798   78570978      11.79G        92.14                                                          49.1    67.44[^b^](#table-1fn3){ref-type="fn"}   

  bE_AP_2      77,558,096    76,635,112    11.5G                                                          92.83   48.42                                    16.29[^a^](#table-1fn2){ref-type="fn"}

  80,037,182   79,108,450    11.87G        92.81                                                          48.63   69.38[^b^](#table-1fn3){ref-type="fn"}   

  bE_AP_3      75,686,054    74,877,152    11.23G                                                         92.91   48.65                                    13.96[^a^](#table-1fn2){ref-type="fn"}

  78,470,990   77,655,916    11.65G        92.89                                                          48.85   71.53[^b^](#table-1fn3){ref-type="fn"}   
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

Clean data were obtained from raw data by removing reads containing adapter, ploy-N and low quality reads.

Clean reads were mapped to *Escherichia coli* genome.

Clean reads were mapped to *Mus musculus* genome.

Validation of dual RNA-seq data by qRT-PCR
------------------------------------------

To confirm the results of the RNA-seq analysis, 17 highly expressed DEGs were randomly selected for further validation using qRT-PCR (details in [Table S1](#supp-2){ref-type="supplementary-material"}). The trends of up- and down-regulation for 16 of the genes were consistent with the results of the Illumina sequencing analysis, except the *Vask* gene ([Figs. 1A](#fig-1){ref-type="fig"} and [1B](#fig-1){ref-type="fig"}). In addition, the Pearson correlation coefficients (*R*^2^) of bEnd.3 cells and APEC strain were 0.954 and 0.876, respectively, indicating that the results of both techniques correlated strongly ([Figs. 1C](#fig-1){ref-type="fig"} and [1D](#fig-1){ref-type="fig"}), thus confirming the reliability and accuracy of the transcriptome analysis.

![Validation of dual RNA-seq analysis.\
(A) qRT-PCR analysis of bEnd.3 transcriptome representative genes identified by RNA-seq. The *x*-axis represents individual genes and the *y*-axis fold change in expression determined by RNA-seq (black bars) or qRT-PCR (white bars). All data are shown as means ± SD. BEnd.3 transcriptome representative genes are *Hilpda* (hypoxia inducible lipid droplet associated), *Nfkbia* (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha), *Tnfaip3* (tumor necrosis factor, alpha-induced protein 3), *Apold1* (apolipoprotein L domain containing 1), *Ctgf* (connective tissue growth factor), Pxn (paxillin), *Tjp2* (tight junction protein 2), *Lama5* (laminin, alpha 5) and *Ogfod1* (2-oxoglutarate and iron-dependent oxygenase domain containing 1). (B) qRT-PCR analysis of BEnd.3 transcriptome representative genes identified by RNA-seq. APEC strain transcriptome representative genes are *clbS* (colibactin self-protection protein clbS), *neuC* (UDP-N-acetylglucosamine 2-epimerase (hydrolyzing)), *tf* (type 1 fimbrial protein), *rfbC* (dTDP-4-dehydrorhamnose 3,5-epimerase), *clbI* (colibactin polyketide synthase ClbI), *clbH* (colibactin non-ribosomal peptide synthetase clbH), *VasK* (type VI secretion protein VasK) and *clbC* (colibactin polyketide synthase ClbC). All data are shown as means ± SD. (C) The correlation coefficient (*R*^2^) between the two data sets of bEnd.3 cells. The *x*-axis represents the log~2~ fold change in expression determined by qRT-PCR and the *y*-axis represents the log~2~ fold change in expression determined by RNA-seq. (D) The correlation coefficient (*R*^2^) between the two data sets of APEC strain. The *x*-axis represents the log~2~ fold change in expression determined by qRT-PCR and the *y*-axis represents the log~2~ fold change in expression determined by RNA-seq.](peerj-08-9172-g001){#fig-1}

Analysis of changes in the bEnd.3 cells transcriptome during infection
----------------------------------------------------------------------

The hierarchical clustering ([Fig. 2A](#fig-2){ref-type="fig"}) and RNA-seq sample Pearson correlation analysis ([Fig. 2B](#fig-2){ref-type="fig"}) of gene expression datasets from the infected and uninfected bEnd.3 cells demonstrated high reproducibility within group. The DESeq2 R package identified 5,552 DEGs between the uninfected and infected bEnd.3 cells, among which 3,134 were upregulated and 2,418 were downregulated in response to infection ([Fig. 2C](#fig-2){ref-type="fig"}; \|log~2~-fold change\| ≥ 0.5 and adjusted *P* value \< 0.05).

![Differential expression overview profiles of bEnd.3 cells transcriptome data.\
(A) Heat maps of bEnd.3 gene expression during infection or mock infection samples. The read counts of each cellular mRNA were normalized by the sum of the total reads. Colors from white to red indicate upregulated cellular genes; colors from white to blue indicate downregulated cellular genes. (B) Pearson correlation between infection and mock infection samples. (C) Volcano plot of *P* values as a function of weighted fold change for mRNAs in infected and control groups. The vertical dotted line delimits up- and down-regulation. Red plots represent significant upregulated and green plots represent significant downregulated. (\|log~2~ fold change\| of ≥0.5, corrected *P* \< 0.05).](peerj-08-9172-g002){#fig-2}

Functional classification of the DEGs using KEGG pathway enrichment analysis revealed their association with 273 pathways, indicating that many host genes, whose expression changed in response to infection, were enriched in signal transduction and immune response. The top 20 pathways are shown in [Figs. 3A](#fig-3){ref-type="fig"} and [3B](#fig-3){ref-type="fig"}. The DEGs were also annotated by GO enrichment analysis using the GOseq R package, which showed that the DEGs were enriched in 12,833 GO terms, including 9,505 biological process terms, 1,158 cellular component terms and 2,152 molecular function terms. The majority of the top 30 enriched GO terms (23/30) were classified as biological processes, details of which are shown in [Fig. 3C](#fig-3){ref-type="fig"}. This study focused on the interesting changes in the bEnd.3 cells, including DEGs responsible for altering the integrity of host cell junctional complexes, actin cytoskeletal rearrangements, extracellular matrix (ECM) degradation, immune activation, and inflammatory responses ([Table 2](#table-2){ref-type="table"}; [Table S2](#supp-3){ref-type="supplementary-material"}).

![Enrichment analysis of KEGG pathways and GO terms for DEGs in bEnd.3 cells.\
(A and B) The top 20 enriched KEGG pathways were classified as human disease (9/20, Salmonella infection and Legionellosis etc), endocrine system (4/20, Estrogen signaling pathway and Oxytocin signaling pathway etc), signal transduction (2/20, HIF-1 signaling pathway, TNF signaling pathway) and other pathways. The size of each circle represents the number of DEGs in each pahway (larger circles represent more DEGs) and the color represents the corrected *P* value of each pathway. Red bars represent significant upregulated, blue bars represent significant downregulated and white bars represent no expression or no significant expression. (C) In the top 30 enriched GO terms, most terms (23/30) were classified as biological process, seven of them were belonged to cellular component.Red bars represent significant upregulated and blue bars represent significant downregulated (\|log~2~ fold change\| ≥0.5, \*corrected *P* \< 0.05).](peerj-08-9172-g003){#fig-3}
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###### DEGs of bEnd.3 cells between the two groups.

Different expression genes of bEnd.3 cells between the infection and mock-infection group.
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                                                        Components     Genes      log~2~                                   padj                                                     Description
  ----------------------------------------------------- -------------- ---------- ---------------------------------------- -------------------------------------------------------- --------------------------------
  DEGs related to cell junctional complexes                                                                                                                                         
  Tight junctions (TJs)                                 Claudins       *Cldn5*    −0.51506                                 0.000166                                                 claudin 5
  Adherens junctions (AJs)                              Cadherin       *Cdh5*     −0.73355                                 3.27E−19                                                 cadherin 5
  *Cdh24*                                               −0.78667       0.041049   cadherin-like 24                                                                                  
  nectin                                                *Nectin1*      −1.7466    1.22E−50                                 nectin cell adhesion molecule 1                          
  *Nectin2*                                             −0.53373       0.00102    nectin cell adhesion molecule 2                                                                   
  *Nectin3*                                             0.59157        3.14E−07   nectin cell adhesion molecule 3                                                                   
  DEGs related to actin cytoskeletal rearrangements                                                                                                                                 
  Regulation of actin cytoskeleton                                     *Cfl1*     −0.54554                                 3.27E−10                                                 cofilin 1, non-muscle
                                                        *Actn1*        −0.60337   2.06E−09                                 actinin, alpha 1                                         
                                                        *Limk1*        −0.6284    0.001253                                 LIM-domain containing, protein kinase                    
                                                        *Pxn*          −0.83324   3.61E−10                                 paxillin                                                 
                                                        *Actn4*        −1.6743    1.54E−27                                 actinin alpha 4                                          
                                                        *Actb*         2.0004     1.10E−136                                actin, beta                                              
                                                        *Itgav*        0.78575    1.76E−21                                 integrin alpha V                                         
                                                        *Rock1*        0.61447    2.59E−12                                 Rho-associated coiled-coil containing protein kinase 1   
                                                        *Rock2*        0.50308    2.05E−09                                 Rho-associated coiled-coil containing protein kinase 2   
  DEGs of immune activation and inflammatory response                                                                                                                               
  Pattern recognition receptors (PRRs)                                 *Tlr13*    1.2499                                   6.48E−16                                                 toll-like receptor 13
                                                        *Tlr4*         0.82039    2.48E−17                                 toll-like receptor 4                                     
  Complement system                                                    *C3*       −0.58759                                 0.005068                                                 complement component 3
                                                        *C3ar1*        0.74408    2.90E−05                                 complement component 3a receptor 1                       
                                                        *Cfp*          −0.99477   3.44E−05                                 complement factor properdin                              
                                                        *Masp1*        3.9332     0.00077                                  mannan-binding lectin serine peptidase 1                 
  Chemokines                                            C subfamiliy   Xcr1       1.749                                    6.96E−06                                                 chemokine (C motif) receptor 1
  C--C subfamiliy                                       *Ccl2*         0.61885    0.000328                                 chemokine (C--C motif) ligand 2                          
  *Ccrl2*                                               0.72992        0.03855    chemokine (C--C motif) receptor-like 2                                                            
  C--X3--C subfamiliy                                   *Cx3cl1*       −0.54859   0.000456                                 chemokine (C--X3--C motif) ligand 1                      
  C--X--C subfamiliy                                    *Cxcl1*        1.7688     2.22E−06                                 chemokine (C--X--C motif) ligand 1                       
  *Cxcl16*                                              1.4227         0.000779   chemokine (C--X--C motif) ligand 16                                                               
  *Cxcl2*                                               1.7977         0.00055    chemokine (C--X--C motif) ligand 2                                                                

The BBB is a highly specialized structural and biochemical barrier; its properties are primarily determined by junctional complexes between the endothelial cells (ECs), comprising of adherens junctions (AJs) and tight junctions (TJs). In this study, genes encoding AJs (e.g., *Cdh5, Cdh24, Pcdh1, Pcdhgc3, Nectin1* and *Nectin2*), which were involved in supporting cadherin association and regulating out-in signaling processes, were downregulated, but *Nectin3* was upregulated in *E. coli*-infected bEnd.3 cells. Moreover, genes encoding TJs (e.g., *Cldn5, Tjap1, Actn1* and *Actn4*), which are involved in sealing the interendothelial cleft, were downregulated in the infected cells. These findings indicated that the structural integrity, permeability and paracellular barriers of the BBB were destroyed during infection.

Previously, it has been shown that the actin cytoskeleton was rearranged and the ECM, with related receptors, were closely regulated when NMEC traversed the BBB ([@ref-40]; [@ref-34]). In the present study, some DEGs (*Rock1*, *Rock2*, *Vav3*, *Itgav*, *Lamc2*, *Sdc4*, *Gp1ba*, and *Thbs1*) related to actin arrangement and the ECM were upregulated, while other DEGs with similar functions (*Actn4*, *Actn1*, *Itgb4, Pxn*, *Cfl1*, *Wasf1*, *Wasl*, *Dag1*, *Col5a3*, *Col5a1*, *Itga5*, *Col27a1*, *Lama5*, *Itgb4*, *Fn1*, *Agrn*, *Comp*, *Col1a1* and *Hspg2*) were downregulated. These findings suggested an increase in Rho/ROCK pathway activation, F-actin cytoskeleton rearrangement, and BBB permeability.

Inflammation is a hallmark of bacterial meningitis and is mediated mainly by cytokines and chemokines, which occurs in response to bacteria or their products. Additionally, *Tlr4*, *Tlr13, Cxcl2*, *Cxcl1*, *Xcr1*, *Cxcl16*, *Nfkbia*, *Tnfaip3*, *Il6, Casp12*, *Nod2*, *Ccl2*, *Vcam1*, *Ncf2*, *Cfd*, *Cd46* and *C3ar1* were upregulated and *C3* was downregulated in the infection group, which suggested that the permeability of the BBB increased and the recruitment of monocytes, neutrophils, T cells, and natural killer cells was enhanced during the infection process.

*E. coli* transcriptome changes during bEnd.3 cells infection
-------------------------------------------------------------

The hierarchical clustering ([Fig. 4A](#fig-4){ref-type="fig"}) and RNA-seq sample Pearson correlation analysis ([Fig. 4B](#fig-4){ref-type="fig"}) of gene expression datasets demonstrated high reproducibility within group from the infected and mock-infected bEnd.3 cells. The DESeq2 R package identified 1,894 DEGs between the two infection conditions, including 969 upregulated and 925 downregulated genes ([Fig. 4C](#fig-4){ref-type="fig"}, \|log~2~ fold change\| ≥ 1 and adjusted *P-*value \< 0.05).

![Differential expression overview profiles of APEC strain transcriptome data.\
(A) Heat maps of APEC strain gene expression during infection or control samples. The read counts of each cellular mRNA were normalized by the sum of the total reads. Colors from white to red indicate upregulated cellular genes; colors from white to blue indicate downregulated cellular genes. (B) Pearson correlation between infection and control samples. (C) Volcano plot of *P*-values as a function of weighted fold change for mRNAs in infection and control groups. The vertical dotted line delimits up- and down-regulation. Red plots represent significant upregulated and green plots represent significant downregulated (\|log~2~ fold change\| ≥1, corrected *P* \< 0.05).](peerj-08-9172-g004){#fig-4}

KEGG pathway enrichment analysis was used to functionally classify the DEGs for 88 pathways, revealing that many *E. coli* genes were enriched in amino acid and energy metabolism when APEC was cultured with the cells. The top 20 pathways are shown in [Figs. 5A](#fig-5){ref-type="fig"} and [5B](#fig-5){ref-type="fig"}. The DEGs were also annotated by GO enrichment analysis using the GOseq R package, and enriched for 2,482 GO terms, including 1,376 biological process terms, 311 cellular component terms and 795 molecular function terms. The majority of the top 30 enriched GO terms (18/30) were classified as biological processes, which are shown in detail in [Fig. 5C](#fig-5){ref-type="fig"}. In this study, we also identified several interesting changes in *E. coli*, particularly in the DEGs related to virulence factors, protein export systems and amino acid metabolism ([Table 3](#table-3){ref-type="table"}; [Table S3](#supp-4){ref-type="supplementary-material"}).

![Enrichment analysis of KEGG pathways and GO terms for DEGs in APEC strain.\
(A and B) The top 20 enriched KEGG pathways were classified as amino acid metabolism (7/20, Valine, leucine and isoleucine biosynthesis and Selenocompound metabolism, etc.), lipid metabolism (2/20, Biosynthesis of unsaturated fatty acids and Glycerolipid metabolism), energy metabolism (2/20, Nitrogen metabolism and Oxidative phosphorylation) and othe pathways. The size of each circle represents the number of DEGs in each pahway (larger circles represent more DEGs) and the color represents the corrected *P* value of each pathway. Red bars represent significant upregulated, blue bars represent significant downregulated and white bars represent no expression or no significant expression. (C) In the top 30 enriched GO terms, most terms (18/30) were classified as biological process, eight of them belonged to cellular component and four of them were classified as molecular function. Red bars represent significant upregulated and blue bars represent significant downregulated (\|log~2~ fold change\| ≥1, \*corrected *P* \< 0.05).](peerj-08-9172-g005){#fig-5}
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###### DEGs of APEC strain between two groups.

Different expression genes of APEC strain between the infection and mock-infection group.
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  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                              Components      Gene\     log~2~\       padj                                                                                   Description
                                                              name      Fold Change                                                                                          
  ------------------------------------------- --------------- --------- ------------- -------------------------------------------------------------------------------------- ----------------------------------
  Virulence factors related to meningitis                                                                                                                                    

  Outer membrane protein                      CXG97_RS20855   --        −2.3638       3.43E−06                                                                               membrane protein

  CXG97_RS13750                               --              −1.8361   0.0083262     membrane protein                                                                       

  CXG97_RS15480                               --              −1.7665   0.014095      membrane protein                                                                       

  CXG97_RS10635                               --              −1.1948   0.039525      membrane protein                                                                       

  CXG97_RS12085                               --              3.121     3.42E−09      membrane protein                                                                       

  CXG97_RS18795                               --              1.5797    0.003432      membrane protein                                                                       

  CXG97_RS10035                               --              1.1784    0.032157      membrane protein                                                                       

  CXG97_RS08525                               --              1.3149    0.015745      autotransported outer membrane protein involved in cell adhesion                       

  CXG97_RS01930                               --              1.7816    0.0014647     autotransporter outer membrane beta-barrel domain-containing protein                   

  CXG97_RS01635                               --              1.4776    0.0098823     autotransporter outer membrane beta-barrel domain-containing protein                   

  CXG97_RS09010                               --              1.6293    0.049761      fimbrial biogenesis outer membrane usher protein                                       

  CXG97_RS18505                               --              1.3315    0.045966      fimbrial biogenesis outer membrane usher protein                                       

  CXG97_RS09580                               *slyB*          1.3411    0.0099186     outer membrane lipoprotein SlyB                                                        

  CXG97_RS15430                               --              1.5911    0.0023044     outer membrane protein assembly factor BamD                                            

  CXG97_RS15540                               --              1.2863    0.015568      outer membrane protein assembly factor BamE                                            

  fimbrial                                    CXG97_RS01490   --        −3.3352       2.07E−05                                                                               fimbrial chaperone EcpB

  CXG97_RS17665                               --              −1.2869   0.0229        fimbrial protein SteB                                                                  

  CXG97_RS25945                               *fimA*          −1.1275   0.041784      type 1 fimbriae major subunit                                                          

  CXG97_RS13610                               --              −1.7529   0.002143      flagella biosynthesis regulator Flk                                                    

  CXG97_RS25950                               --              −2.2246   0.00011843    fimbrin fimI                                                                           

  CXG97_RS09010                               --              1.6293    0.049761      fimbrial biogenesis outer membrane usher protein                                       

  CXG97_RS09025                               --              2.7839    2.36E−07      fimbrial chaperone protein FimC                                                        

  fimbrial                                    CXG97_RS09015   --        1.7675        0.0015729                                                                              fimbrial chaperone protein FimC

  CXG97_RS17675                               --              1.996     8.94E−05      type 1 fimbrial protein                                                                

  CXG97_RS20510                               --              1.2399    0.02421       type 1 fimbrial protein                                                                

  CXG97_RS09020                               --              2.3148    5.86E−06      Fml fimbriae subunit                                                                   

  flagellin                                   CXG97_RS11050   --        1.2589        0.039065                                                                               flagellin FliC

  LPS biosynthesis                            CXG97_RS21640   --        2.4423        3.2651E−06                                                                             ligase

  CXG97_RS21660                               --              1.9943    0.00014874    LPS 1%2C2-glucosyltransferase                                                          

  CXG97_RS21655                               --              2.0378    0.00015131    LPS core heptose(II) kinase RfaY                                                       

  CXG97_RS21665                               --              1.8557    0.00042876    lipopolysaccharide 3-alpha-galactosyltransferase                                       

  CXG97_RS06255                               --              −1.3255   0.017077      lipid A biosynthesis lauroyl acyltransferase                                           

  CXG97_RS21670                               --              1.2497    0.019185      lipopolysaccharide core heptose(I) kinase RfaP                                         

  CXG97_RS21630                               --              −1.7497   0.038733      ADP-heptose--LPS heptosyltransferase                                                   

  Proteins export and amino acid metabolism                                                                                                                                  

  Protein export                              CXG97_RS19815   *SecY*    2.0511        4.25E−05                                                                               protein translocase subunit SecY

  CXG97_RS23005                               *tatC*          1.9541    0.00021961    twin-arginine translocase subunit TatC                                                 

  CXG97_RS02115                               *YajC*          1.7879    0.00069815    preprotein translocase subunit YajC                                                    

  CXG97_RS22995                               *TatA*          1.3288    0.012952      twin-arginine translocase subunit TatA                                                 

  CXG97_RS23000                               *TatB*          1.2944    0.014643      twin-arginine translocase subunit TatB                                                 

  CXG97_RS02125                               *SecF*          2.2484    0.020017      protein translocase subunit SecF                                                       

  CXG97_RS21575                               *SecB*          1.237     0.025291      protein-export protein SecB                                                            

  CXG97_RS19155                               *SecG*          1.1816    0.027567      protein-export membrane protein SecG                                                   

  Arginine and proline metabolism             CXG97_RS23620   *argB*    3.3547        1.35E−05                                                                               acetylglutamate kinase

  CXG97_RS17080                               *arcC*          1.6337    0.008478      carbamate kinase                                                                       

  CXG97_RS08705                               *patD*          1.3149    0.037641      gamma-aminobutyraldehyde dehydrogenase                                                 

  CXG97_RS25795                               *argF*          8.588     1.37E−24      ornithine carbamoyltransferase                                                         

  CXG97_RS03780                               *speF*          1.5823    0.034956      ornithine decarboxylase SpeF                                                           

  CXG97_RS06060                               *putA*          −3.5858   0.005959      bifunctional proline dehydrogenase/L-glutamate gamma-semialdehyde dehydrogenase PutA   

  CXG97_RS10130                               *astB*          −4.4096   0.006318      succinylarginine dihydrolase                                                           

  CXG97_RS10135                               *astD*          −5.5193   0.000153      N-succinylglutamate 5-semialdehyde dehydrogenase                                       

  CXG97_RS17430                               *speB*          −1.8935   0.000611      agmatinase                                                                             

  CXG97_RS23160                               *glnA*          −1.458    0.009095      glutamate--ammonia ligase                                                              
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A critical step in the development of meningitis is the adhesion and invasion of ECs. Therefore, virulence factors related to fimbriae, flagella, outer membrane proteins, and lipoproteins are highly important for allowing pathogenic *E. coli* to resist blood flow and cross the BBB.

The RNA-seq data showed that the expression of seven genes related to outer membrane proteins (e.g., CXG97_RS09580, CXG97_RS01930), eight fimbrial genes (e.g., CXG97_RS09010, CXG97_RS09025), one flagellin gene (CXG97_RS11050), two pilus genes (CXG97_RS17695 and CXG97_RS17680), and one lipoprotein gene (CXG97_RS19095) increased significantly during infection, whereas the expression of nine fimbrial genes (e.g., CXG97_RS01490, CXG97_RS25950) decreased during infection ([Table 3](#table-3){ref-type="table"}; [Table S3](#supp-4){ref-type="supplementary-material"}).

Lipopolysaccharide (LPS) is produced by most Gram-negative bacteria and can activate the host immune system via TLR4. RNA-seq data revealed that eight DEGs were enriched in the LPS biosynthesis pathway, five of which (e.g., CXG97_RS21640, CXG97_RS21660) were upregulated in the infection group. Colicins are class III bacteriocins, which are produced during nutrient or oxygen stress and regulated by the SOS response ([@ref-63]). The expression of six genes related to colicin biosynthesis and transport (e.g., CXG97_RS26815, CXG97_RS27750) increased significantly during infection. In addition, thirteen colibactin genes (e.g., CXG97_RS11550, CXG97_RS11545), which induce chromosomal instability and DNA damage in eukaryotic cells and lead to EC senescence and immune cell apoptosis, were downregulated during infection, while only one colibactin gene (CXG97_RS11495) was upregulated. The type VI secretion system (T6SS) contributes to the pathogenicity of bacteria ([@ref-82]) and bacteria--bacteria interactions ([@ref-4]). Four T6SS genes (e.g., CXG97_RS01210, CXG97_RS01220) were downregulated during infection in the present study. ABC transporters are essential bacterial virulence factors, which play roles in the secretion of toxins and antimicrobial agents, and are associated with physiological processes ([@ref-15]). In RNA-seq data, numerous DEGs were enriched in the ABC transporter pathway, with CXG97_RS18120, CXG97_RS13545, CXG97_RS23390 and CXG97_RS05305 being the most significantly upregulated genes in the APEC strain cultured with cells. These results suggested that the occurrence of meningitis was related to synergistic effects of many virulence factors.

Compared to the negative control, the prokaryotic protein export pathway was one of the most enriched *E. coli* KEGG pathways, which is composed of the general secretory system (Sec system), twin-arginine translocase (Tat) system, and a single peptide. The Sec and Tat systems are responsible for the transport of unstable or unfolded bacterial structural proteins to the periplasm or cytoplasmic membrane. Some genes (*secYFBG*, *tatABC*, *yajc* and *lepB*) from three parts of this pathway were upregulated in the infected groups, which suggested that protein secretion may be increased in the infected group. Moreover, several DEGs related to amino acid metabolism in APEC changed in response to bEnd.3 cells, as compared to those cultured in DMEM. The majority of these genes, which were involved in arginine and proline metabolism (*argB, astDB*, *speBF* and *patD*), histidine metabolism (*hisHDFAF*), and valine, leucine and isoleucine biosynthesis (*leuCB* and *ilvA*), were downregulated in the infected samples, suggesting that APEC may encounter a difficult and complex nutritional environment during the infection process.

Discussion
==========

Bacterial meningitis is an inflammatory disease of the CNS, which not only causes high morbidity and mortality but also leaves survivors with long-term neurological sequelae. To infect the CNS, bacteria must interact with and cross the BBB via a critical step involving the adherence and invasion of BMECs, an important component of the BBB. In the present study, we used RNA-seq to measure genome-wide transcriptional changes in both APEC and bEnd.3 cells, including cell junctional complexes, cell signaling, inflammatory responses, bacterial adhesion and invasion factors and metabolic competition for similar nutritional substrates. The findings of the present study may contribute toward an improved understanding of the microbe-cell interaction during the invasion process.

TJ and AJ proteins can form junctional complexes and thus play important roles in maintaining the integrity of the BBB ([@ref-85]). We found that major components of TJs and AJs, such as *Cldn5* and *Cdh5*, were downregulated in infected cells. *Cdh5* is involved in neuroinflammation development, BBB dysregulation ([@ref-24]), and leukocyte transmigration in vitro ([@ref-53]), and affects the expression of other TJ and AJ proteins ([@ref-17]; [@ref-53]). Conversely, *Cldn5* highly expressed in ECs in the CNS ([@ref-13]; [@ref-51]), which plays a key role in the paracellular barrier and forms mechanical links to maintain the structural integrity and high electrical resistance of vasculature ([@ref-1]). The changes in *Cdh5 and Cldn5* expression observed in the present study are consistent with the previous findings reported in a *Staphylococcus aureus* and *group B Streptococcus* model of meningitis ([@ref-39]; [@ref-47]). In addition, *Cdh5* controls *Cldn5* by triggering its transcriptional repression via *FoxO1* and β*-catenin* ([@ref-68]). Transcriptome data in the present study revealed a significant decrease in *FoxO1* expression during infection but only a slight increase in β*-catenin* expression, which may be related to the up-regulation of β-catenin protein levels and the activation of Wnt/β-catenin signaling by LPS ([@ref-77]). Moreover, Wnt/β-catenin signaling was shown to be involved in BBB development, where its blockade decreased *Cdh5* expression in primary ECs of newborn mouse brain but not in that of the adult ([@ref-31]). The results of the present study as well as previous studies ([@ref-39]; [@ref-47]) suggest that *Cdh5* and *Cldn5* are major determinants of BBB deterioration during infection, while Wnt/β-catenin signaling may contribute to the maintenance of BBB integrity. However, further studies are required to investigate the complex relationship between *Cdh5*, *Cldn5* and Wnt/β-catenin signaling during the development of *E. coli* meningitis.

As a dual (physical and immunological) barrier, the BBB is also a central determinant of protective homeostatic surveillance during CNS infections ([@ref-41]). CNS ECs are semiprofessional antigen-presenting cells that present antigens to T cells and regulate the multistep cascade for immune cell trafficking into the CNS ([@ref-49]). In the present study, *Tlr4* and *Tlr13* were upregulated in infected cells. However, a previous study on mouse meningitis induced by *E. coli* showed that TLRs were activated in brain tissues, with elevated *Tlr2, Tlr4* and *Tlr7* expression ([@ref-7]). TLR activation has also been shown to modulate microvascular EC permeability and the expression of coagulation pathway intermediaries ([@ref-33]). *Tlr13* was highly expressed in almost all mouse CNS cell types and specifically detected 23S ribosomal RNA from *E. coli* ([@ref-44]). Recent studies have identified that the recognition of *E. coli* mRNA stimulated helper T cell differentiation, promoted vaccine responses, and helped to distinguish between live and dead microbes ([@ref-59]; [@ref-72]). To our knowledge, this is the first study to report the high expression of *Tlr13* in *E. coli* meningitis model in vitro. However, further investigations are necessary to elucidate the specific microbial components that activate Tlr13 in *E. coli* meningitis and reveal the details of the related pathways involved in infection. Moreover, future studies should investigate TLR inhibitors as potential targets to prevent serious meningitis-related complications.

Following inflammatory activation, host cells release cytokines and chemokines to maintain immune surveillance, facilitate leukocyte traffic, and recruit other inflammatory factors ([@ref-69]). In the present study, *Cxcl1, Cxcl2* and *Cxcl16* were significantly upregulated in infected cells. A similar innate immune response was previously observed in different bacterial meningitis as well. *Cxcl1*, *Cxcl2* and *CXCL16* were associated with the migration of immune cells to sites of inflammation, matrix metalloproteinase activity, increased cell--cell adhesion, NF-кB-dependent cell proliferation, and proinflammatory gene transcription ([@ref-10]; [@ref-25]; [@ref-26]; [@ref-29]; [@ref-61]; [@ref-73]). In addition, *Cxcl1* and *Cxcl2* have been shown to alter human BMEC permeability and disrupt EC junctions during the migration of neutrophils and monocytes ([@ref-25]; [@ref-79]).

The mechanism of *E. coli* pathogenesis involves complex patterns of adhesion, protein export into host cells, changes in signaling mechanisms, impaired immune responses with colonization, disrupted membrane potential, and cytoskeletal manipulation ([@ref-5]; [@ref-30]; [@ref-38]). In the present study, many bacterial DEGs related to fimbrial and flagellin components were upregulated in the infection group. Type 1 fimbriae are mainly formed by FimAGHF proteins and mediate the mannose-sensitive adhesion of *E. coli* to various eukaryotic cells ([@ref-27]; [@ref-42]; [@ref-71]). Conversely, the expression of S fimbriae in *E. coli* promoted adhesion to cow, human, and rat BMECs but not the systemic vascular endothelium ([@ref-57]). Moreover, it has been shown that flagella, the locomotive organelles of bacteria, are an association factor rather than an invasion factor in human BMECs ([@ref-55]). The results of the present study also indicated that fimbrial and flagellin components were highly important virulence factors of the APEC XM strain for BBB attachment and invasion.

*E. coli* exerts physiological or pathogenic functions by exporting proteins via eight different systems ([@ref-12]). In the present study, many DEGs (*secYFBG* and *LepB)* related to the Sec system were upregulated in the infection group. *SecB* plays a crucial role as a chaperone during protein secretion by binding to precursors and delivering them to the membrane for translocation. Previous studies have shown that many virulence factors, such as P pilus, type 1 pilus, curli, OmpT and OmpA, were secreted into the extracellular environment or localized in the outer membrane by the SecYEG complex or SecB chaperone ([@ref-2]; [@ref-65]; [@ref-66]). Recently, *LepB* has been proved to be a potential target for an attractive new antibacterial agent due to its crucial role in the Sec pathway; LepB inhibition leads to preprotein accumulation at the phospholipid bilayer and thus cell death ([@ref-16]; [@ref-22]). On the basis of these results, Sec pathway-mediated secretion may play an important role in bacterial pathogenesis. Thus, Sec pathway-associated proteins could be potential antibiotic drug targets for the prevention and treatment of meningitis. Another major component of the protein export pathway is the Tat system. In the present study, the three primary components of the Tat system (*tatABC)* were upregulated in the infected group. The Tat system was shown to take part in the development of bacteremia as well as the production of Shiga toxin 1 (Stx1) and H7 flagellin ([@ref-62]). Therefore, these results suggest that the Tat system may have a potential role in virulence during meningitis.

In addition to the deterioration of physical and immunological barrier functions, host cells and pathogens fiercely competed for nutrition. Indeed, the metabolic competition between the host and bacteria could influence both bacterial virulence and host responses, which determine the outcome of infection ([@ref-52]). In the present study, we identified a series of DEGs related to arginine and proline metabolism, which are particularly important nutrients for the host--pathogen interaction. Arginine is the unique substrate for nitric oxide synthase (NOS) to generate nitric oxide (NO) ([@ref-54]), which has a variety of physiological functions, including vasodilation, leukocyte activation, and killing of virus and bacteria in diseases ([@ref-11]). In the present study, four host genes (*Gm15587*, *Nos2*, *Pycr1*, *Arg2*) were enriched in this metabolic pathway, two of which (*Nos2*, *Pycr1*) were downregulated in the infection group. *Nos2* encoded a NOS and contributed to BBB breakdown and thus early mortality in murine *Streptococcus pneumoniae* meningitis ([@ref-78]). Previous studies showed that *E. coli* utilized arginine via the arginine decarboxylase and the arginine succinyltransferase pathway to produce polyamines (putrescine, spermidine, and spermine) for proliferation or survival in an acidic environment ([@ref-60]; [@ref-64]). Since arginase and iNOS have the same substrate, *E. coli* may exploit their competition to block NO production and thus avoid being killed by NO in a similar manner to other pathogens ([@ref-9]; [@ref-19]; [@ref-70]). In our RNA-seq data set, some DEGs related to arginine and proline metabolism (*argBF, arcC, patD*, and *speF*) were upregulated in the infection group, while others (*putA*, *astBD*, *speB* and *glnA*) were downregulated. On the basis of these results, arginine/ornithine ABC transporters may be an effective target for preventing meningitis. Furthermore, the simultaneous changes in arginine and proline metabolism in the host and microbe may provide novel insights into nutrient and metabolite competition that occurs during meningitis development. Further experiments are required to explore this field and discover the molecular mechanisms underlying the host--pathogen relationship during infection.

Conclusion
==========

This study provided a comprehensive overview of the transcriptomic changes that occurred when APEC infected the bEnd.3 cells. APEC may exploit the degradation of cell junctional connections to invade the BBB and secrete virulence factors to promote bacterial infection. Meanwhile, bEnd.3 cells resisted the bacterial infection via immune activation and inflammatory response. Therefore, this study provides insights into the process of bacterial invasion and the subsequent host defense mechanism, which can be used as reference for further investigations in this field.
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###### Bacterial adherence and invasion of bEnd.3 cells.

Adherence to and invasion of bEnd.3 cells by APEC strain (at MOI of 100). Data are means + standard errors of three independent experiments, each performed in triplicate. An asterisk indicates that the adherence and invasion values of others' time points were significantly higher than the values of the first one hour at *P*-value \< 0.01.
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